RxDoctor Payments Data

Robin Brody, MD

Otolaryngology/Facial Plastic Surgery · Hackensack, NJNPI 1841239423

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.4% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by GSK at 29.9% of the total. 2025 is the largest year on record at $843, 5.3 times the $160 reported in 2019.

$2,025in general payments, 2019–2025

Across 96 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$606
  • Aerin Medical Inc.$300
  • Sanofi$272
  • Regeneron Healthcare Solutions, Inc.$188
  • Stryker$127
  • Sanofi-aventis U.S. LLC$99
  • plus $434 from 10 others

What the payments were for

  • Food & beverage$1,89293%
  • Education$1337%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,025 in reported general payments places this provider in the 55th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.

See all otolaryngology/facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$270,782
Medicare patients
799
Services billed
2,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl430$10,362
Levocetirizine Dihydrochloride298$4,987
DuleraMometasone/Formoterol15$4,808
Fluticasone Propionate218$3,946
Ipratropium Bromide133$3,189
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth27$3,001
Olopatadine Hcl32$2,397
Dexlansoprazole DrDexlansoprazole12$1,889
Fluocinolone Acetonide Oil42$1,021
Albuterol Sulfate HfaAlbuterol Sulfate22$776
Famotidine27$554
Ofloxacin20$501
Omeprazole44$467
ValacyclovirValacyclovir Hcl12$424
Mupirocin46$399

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →